The frequent BRCA1 mutation 1135insA has multiple origins: A haplotype study in different populations

BMC Medical Genetics

Volumn 7, Issue , 2006, Pages

  Rudkin, Teresa M ^a   Hamel, Nancy ^b   Galvez, Maria ^b   Hogervorst, Frans ^c   Gille, Johan J P ^d   Møller, Pål ^e   Apold, Jaran ^f   Foulkes, William D ^a,b,g  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c NETHERLANDS CANCER INSTITUTE   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

^f HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^g MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN;

ARTICLE; BREAST CANCER; CANCER GENETICS; CONTROLLED STUDY; ETHNIC DIFFERENCE; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENOTYPE; HAPLOTYPE; HETEROZYGOTE DETECTION; HUMAN; MICROSATELLITE MARKER; NORWAY; OVARY CANCER; POPULATION GENETICS; SEQUENCE ANALYSIS; BREAST TUMOR; CANADA; DENMARK; ETHNOLOGY; FAMILY HEALTH; FEMALE; FOUNDER EFFECT; GENETICS; ITALY; MOLECULAR EPIDEMIOLOGY; MUTATION; OVARY TUMOR; TUMOR SUPPRESSOR GENE;

BREAST NEOPLASMS; CANADA; DENMARK; FAMILY HEALTH; FEMALE; FOUNDER EFFECT; GENES, BRCA1; HAPLOTYPES; HUMANS; ITALY; MOLECULAR EPIDEMIOLOGY; MUTATION; NORWAY; OVARIAN NEOPLASMS;

EID: 33645025828     PISSN: 14712350     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-7-15     Document Type: Article

References (15)

1. Tonin P, Serova O, Lenoir G, Lynch H, Durocher F, Simard J, Morgan K, Narod S: BRCA1 mutations in Ashkenazi Jewish women. AJHG 1995, 57:189.
2. Tonin PN, Mes-Masson AM, Futreal PA, Morgan K, Mahon M, Foulkes WD, Cole DE, Provencher D, Ghadirian P, Narod SA: Founder BRCA1 and 2 mutations in French Canadian breast and ovarian cancer families. AJHG 1998, 53:1341-51.
3. Durocher F, Tonin P, Shattuck-Eidens D, Skolnick M, Narod SA, Simard J: Mutation analysis of the BRCA1 gene in 23 families with cases of cancer of the breast, ovary, and multiple other sites. J Med Genet 1996, 33:814-19.
4. Peelen T, van Vliet M, Petrij-Bosch A, Mieremet R, Szabo C, van den Ouweland AM, Hogervorst F, Brohet R, Ligtenberg MJ, Teugels E, van der Luijt R, van der Hout AH, Gille JJ, Pals G, Jedema I, Olmer R, van Leeuwen I, Newman B, Plandsoen M, van der Est M, Brink G, Hageman S, Arts PJ, Bakker MM, Devilee P: A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families. Am J Hum Genet 1997, 60:1041-1049.
5. Petrij-Bosch A, Peelen T, van Vliet M, van Eijk R, Olmer R, Drusedau M, Hogervorst FB, Hageman S, Arts PJ, Ligtenberg MJ, Meijers-Heijboer H, Klijn JG, Vasen HF, Cornelisse CJ, van't Veer LJ, Bakker E, van Ommen GJ, Devilee P:BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients. Nat Genet 1997, 17:341-345.
6. Gorski B, Jakubowska A, Huzarski T, Byrski T, Gronwald J, Grzybowska E, Mackiewicz A, Stawicka M, Bebenek M, Sorokin D, Fiszer-Maliszewska L, Haus O, Janiszewska H, Niepsuj S, Gozdz S, Zaremba L, Posmyk M, Pluzanska M, Kilar E, Czudowska D, Wasko B, Miturski R, Kowalczyk JR, Urbanski K, Szwiec M, Koc J, Debniak B, Rozmiarek A, Debniak T, Cybulski C, Kowalska E, Toloczko-Grabarek A, Zajaczek S, Menkiszak J, Medrek K, Masojc B, Mierzejewski M, Narod SA, Lubinski J: A high proportion of founder BRCA1 mutations in Polish breast cancer families. Int J Canc 2004, 110:683-6.
7. Møller P, Borg A, Heimdal K, Apold J, Vallon-Christersson J, Hovig E, Maehle L, Norwegian Inherited Breast Cancer Group, Norwegian Inherited Ovarian Cancer Group: The BRCA1 syndrome and other inherited breast or breast-ovarian cancers in a Norwegian prospective series. Eur J Cancer 2001, 37:1027-1032.
8. Moller P, Heimdal K, Apold J, Fredriksen A, Borg A, Hovig E, Hagen A, Hagen B, Pedersen JC, Maehle L, Norwegian Inherited Breast Cancer Group, Norwegian Inherited Ovarian Cancer Group: Genetic epidemiology of BRCA1 mutations in Norway. Eur J Canc 2001, 37:2428-2434.
9. Dørum A, Hovig E, Tropé, Inganas M, Moller P: Three per cent of Norwegian ovarian cancers are caused by BRCA1 1675delA or 1135insA. Eur J Cancer 1999, 35:779-781.
10. [http://research.nhgri.nih.gov/bic/].
11. Heimdal K, Mæhle L, Apold J, Pedersen JC, Moller P: The Norwegian founder mutations in BRCA1: high penetrance confirmed in an incident cancer series and differences observed in the risk of ovarian cancer. Eur J Cancer 2003, 39:2205-2213.
12. Encyclopædia Britannica. 2003.
13. Liu X, Barker DF: Evidence for effective suppression of recombination in the chromosome 17q21 segment spanning RNU2-BRCA1. AJHG 1999, 64:1427-39.
14. Pisano M, Cossu A, Persico I, Palmieri G, Angius A, Casu G, Palomba G, Sarobba MG, Rocca PC, Dedola MF, Olmeo N, Pasca A, Budroni M, Marras V, Pisano A, Farris A, Massarelli G, Pirastu M, Tanda F: Identification of a founder BRCA2 mutation in Sardinia. Brit J Cancer 2000, 82:553-9.
15. Manning AP, Abelovich D, Ghadirian P, Lambert JA, Frappier D, Provencher D, Robidoux A, Peretz T, Narod SA, Mes-Masson AM, Foulkes WD, Wang T, Morgan K, Fujiwara TM, Tonin PN: Haplotype analysis of BRCA2 8765delAG mutation carriers in French Canadian and Yemenite Jewish hereditary breast cancer families. Human Heredity 2001, 52:116-20.